Marengo Therapeutics, Inc, a clinical-stage biotech company pioneering a new way to activate T cells that target...
Clinical-stage Biotech
PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announces...
K36 Therapeutics Announces Appointment of Benjamin Winograd, MD, PhD, as Chief Medical Officer
![Dr. Benjamin Winograd - Chief Medical Officer at K36 Therapeutics](https://wellnessnews24.com/wp-content/uploads/2023/11/pexels-edward-jenner-4031442-720x530.jpg)
3 min read
K36 Therapeutics, Inc. (“K36”), a clinical-stage biotech company focused on developing its first-in-class MMSET inhibitor KTX-1001 for...
Chime Biologics, a leading CDMO that enables its partners’ success in biologics, and Hope Medicine Inc. (HopeMed), a...